Global Artificial Blood Vessels Market

Artificial Blood Vessels Comprehensive Study by Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, Others), Application (Aortic Disease, Peripheral artery disease, Haemodialysis), End-User (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centres, Specialty Clinics, Others) Players and Region - Global Market Outlook to 2027

Artificial Blood Vessels Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Artificial Blood Vessels Market Scope?
Blocked blood vessels will cause some extremely critical conditions. Hence, it's essential to exchange a broken blood vessel either by artificial vascular prostheses or through different arteries or veins from the body. research institutes have developed artificial blood vessels made of special polymers, that have exceptional mechanical properties. the artificial vessels market is anticipated to witness favorable growth over the forthcoming years, as a result of the increasing prevalence of arteria diseases across the world. Surgeons at the start transplanted veins or arteries from donors to exchange the broken or diseased arteries from the shape. movement vessels from the patient's own body have varied issues like the event of induration of the arteries and several other post-surgery complications. Hence, to avoid such difficulties, artificial vessels were created by researchers, therefore augmenting the market growth. However, the presence of a demanding regulative framework for the approval of artificial vessels can limit market growth. Moreover, the high value related to transplants and surgeries will further impede the market growth.

Artificial Blood Vessels Market Dynamics:
AttributesDetails
Growth Drivers
  • Increasing Prevalence of Aortic Diseases
  • Growing Adoption of Minimally Invasive Surgeries
  • Increasing the Need for Surgeries and Invasive Procedures
Influencing Trends
  • Increase in the Awareness about the Transplant and Surgeries
Restraints
  • High Cost Associated with Transplants and Surgeries
Road Blocks / Challenges
  • Lack of Skilled Professionals
Gaps & Opportunities
  • Technological Advancements in Development of Artificial Blood Vessels


The Artificial Blood Vessels market study is being classified by Type (Polydioxanone, Elastomer, Polyethylene Terephthalate and Others), by Application and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from United States will contribute to the maximum growth of Global Artificial Blood Vessels market throughout the predicted period.

Maquet Cardiovascular (United States), Terumo Group (Japan), Gore (United States), B. Braun (Germany), Bard (United States), Jotec GmbH (Germany), LeMaitre Vascular (United States), Perouse Medical (United Kingdom), Nicast (Israel), ShangHai (China) and Aortica Corporation (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Artificial Blood Vessels market by Type, Application and Region.

On the basis of geography, the market of Artificial Blood Vessels has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
On 19th November 2019, Terumo Group had acquired Aortica Corporation to further boost the market for artificial blood vessels. This strategic partnership would thereby help the companies to have a hold in the market.



Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Artificial Blood Vessels, Venture Capitalists and Private Equity Firms and End-Use Industry

Artificial Blood Vessels Market Study: Important Years
AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Historical Period2017-2021
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Artificial Blood Vessels Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Artificial Blood Vessels industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Polydioxanone
  • Elastomer
  • Polyethylene Terephthalate
  • Others
By Application
  • Aortic Disease
  • Peripheral artery disease
  • Haemodialysis
By End-User
  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgical Centres
  • Specialty Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Prevalence of Aortic Diseases
      • 3.2.2. Growing Adoption of Minimally Invasive Surgeries
      • 3.2.3. Increasing the Need for Surgeries and Invasive Procedures
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Increase in the Awareness about the Transplant and Surgeries
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Blood Vessels, by Type, Application, End-User and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Artificial Blood Vessels (Value)
      • 5.2.1. Global Artificial Blood Vessels by: Type (Value)
        • 5.2.1.1. Polydioxanone
        • 5.2.1.2. Elastomer
        • 5.2.1.3. Polyethylene Terephthalate
        • 5.2.1.4. Others
      • 5.2.2. Global Artificial Blood Vessels by: Application (Value)
        • 5.2.2.1. Aortic Disease
        • 5.2.2.2. Peripheral artery disease
        • 5.2.2.3. Haemodialysis
      • 5.2.3. Global Artificial Blood Vessels by: End-User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Cardiac Catheterization Laboratories
        • 5.2.3.3. Ambulatory Surgical Centres
        • 5.2.3.4. Specialty Clinics
        • 5.2.3.5. Others
      • 5.2.4. Global Artificial Blood Vessels Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Artificial Blood Vessels (Price)
      • 5.3.1. Global Artificial Blood Vessels by: Type (Price)
  • 6. Artificial Blood Vessels: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Maquet Cardiovascular (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Terumo Group (Japan)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Gore (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. B. Braun (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bard (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Jotec GmbH (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LeMaitre Vascular (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Perouse Medical (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nicast (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ShangHai (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Aortica Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Artificial Blood Vessels Sale, by Type, Application, End-User and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Artificial Blood Vessels (Value)
      • 7.2.1. Global Artificial Blood Vessels by: Type (Value)
        • 7.2.1.1. Polydioxanone
        • 7.2.1.2. Elastomer
        • 7.2.1.3. Polyethylene Terephthalate
        • 7.2.1.4. Others
      • 7.2.2. Global Artificial Blood Vessels by: Application (Value)
        • 7.2.2.1. Aortic Disease
        • 7.2.2.2. Peripheral artery disease
        • 7.2.2.3. Haemodialysis
      • 7.2.3. Global Artificial Blood Vessels by: End-User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Cardiac Catheterization Laboratories
        • 7.2.3.3. Ambulatory Surgical Centres
        • 7.2.3.4. Specialty Clinics
        • 7.2.3.5. Others
      • 7.2.4. Global Artificial Blood Vessels Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Artificial Blood Vessels (Price)
      • 7.3.1. Global Artificial Blood Vessels by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Blood Vessels: by Type(USD Million)
  • Table 2. Artificial Blood Vessels Polydioxanone , by Region USD Million (2016-2021)
  • Table 3. Artificial Blood Vessels Elastomer , by Region USD Million (2016-2021)
  • Table 4. Artificial Blood Vessels Polyethylene Terephthalate , by Region USD Million (2016-2021)
  • Table 5. Artificial Blood Vessels Others , by Region USD Million (2016-2021)
  • Table 6. Artificial Blood Vessels: by Application(USD Million)
  • Table 7. Artificial Blood Vessels Aortic Disease , by Region USD Million (2016-2021)
  • Table 8. Artificial Blood Vessels Peripheral artery disease , by Region USD Million (2016-2021)
  • Table 9. Artificial Blood Vessels Haemodialysis , by Region USD Million (2016-2021)
  • Table 10. Artificial Blood Vessels: by End-User(USD Million)
  • Table 11. Artificial Blood Vessels Hospitals , by Region USD Million (2016-2021)
  • Table 12. Artificial Blood Vessels Cardiac Catheterization Laboratories , by Region USD Million (2016-2021)
  • Table 13. Artificial Blood Vessels Ambulatory Surgical Centres , by Region USD Million (2016-2021)
  • Table 14. Artificial Blood Vessels Specialty Clinics , by Region USD Million (2016-2021)
  • Table 15. Artificial Blood Vessels Others , by Region USD Million (2016-2021)
  • Table 16. South America Artificial Blood Vessels, by Country USD Million (2016-2021)
  • Table 17. South America Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 18. South America Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 19. South America Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 20. Brazil Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 21. Brazil Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 22. Brazil Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 23. Argentina Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 24. Argentina Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 25. Argentina Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 26. Rest of South America Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 27. Rest of South America Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 28. Rest of South America Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 29. Asia Pacific Artificial Blood Vessels, by Country USD Million (2016-2021)
  • Table 30. Asia Pacific Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 31. Asia Pacific Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 32. Asia Pacific Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 33. China Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 34. China Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 35. China Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 36. Japan Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 37. Japan Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 38. Japan Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 39. India Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 40. India Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 41. India Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 42. South Korea Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 43. South Korea Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 44. South Korea Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 45. Taiwan Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 46. Taiwan Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 47. Taiwan Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 48. Australia Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 49. Australia Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 50. Australia Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 51. Rest of Asia-Pacific Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 52. Rest of Asia-Pacific Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 53. Rest of Asia-Pacific Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 54. Europe Artificial Blood Vessels, by Country USD Million (2016-2021)
  • Table 55. Europe Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 56. Europe Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 57. Europe Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 58. Germany Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 59. Germany Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 60. Germany Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 61. France Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 62. France Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 63. France Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 64. Italy Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 65. Italy Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 66. Italy Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 67. United Kingdom Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 68. United Kingdom Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 69. United Kingdom Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 70. Netherlands Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 71. Netherlands Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 72. Netherlands Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 73. Rest of Europe Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 74. Rest of Europe Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 75. Rest of Europe Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 76. MEA Artificial Blood Vessels, by Country USD Million (2016-2021)
  • Table 77. MEA Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 78. MEA Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 79. MEA Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 80. Middle East Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 81. Middle East Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 82. Middle East Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 83. Africa Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 84. Africa Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 85. Africa Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 86. North America Artificial Blood Vessels, by Country USD Million (2016-2021)
  • Table 87. North America Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 88. North America Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 89. North America Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 90. United States Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 91. United States Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 92. United States Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 93. Canada Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 94. Canada Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 95. Canada Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 96. Mexico Artificial Blood Vessels, by Type USD Million (2016-2021)
  • Table 97. Mexico Artificial Blood Vessels, by Application USD Million (2016-2021)
  • Table 98. Mexico Artificial Blood Vessels, by End-User USD Million (2016-2021)
  • Table 99. Artificial Blood Vessels: by Type(USD/Units)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Artificial Blood Vessels: by Type(USD Million)
  • Table 112. Artificial Blood Vessels Polydioxanone , by Region USD Million (2022-2027)
  • Table 113. Artificial Blood Vessels Elastomer , by Region USD Million (2022-2027)
  • Table 114. Artificial Blood Vessels Polyethylene Terephthalate , by Region USD Million (2022-2027)
  • Table 115. Artificial Blood Vessels Others , by Region USD Million (2022-2027)
  • Table 116. Artificial Blood Vessels: by Application(USD Million)
  • Table 117. Artificial Blood Vessels Aortic Disease , by Region USD Million (2022-2027)
  • Table 118. Artificial Blood Vessels Peripheral artery disease , by Region USD Million (2022-2027)
  • Table 119. Artificial Blood Vessels Haemodialysis , by Region USD Million (2022-2027)
  • Table 120. Artificial Blood Vessels: by End-User(USD Million)
  • Table 121. Artificial Blood Vessels Hospitals , by Region USD Million (2022-2027)
  • Table 122. Artificial Blood Vessels Cardiac Catheterization Laboratories , by Region USD Million (2022-2027)
  • Table 123. Artificial Blood Vessels Ambulatory Surgical Centres , by Region USD Million (2022-2027)
  • Table 124. Artificial Blood Vessels Specialty Clinics , by Region USD Million (2022-2027)
  • Table 125. Artificial Blood Vessels Others , by Region USD Million (2022-2027)
  • Table 126. South America Artificial Blood Vessels, by Country USD Million (2022-2027)
  • Table 127. South America Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 128. South America Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 129. South America Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 130. Brazil Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 131. Brazil Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 132. Brazil Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 133. Argentina Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 134. Argentina Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 135. Argentina Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 136. Rest of South America Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 137. Rest of South America Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 138. Rest of South America Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 139. Asia Pacific Artificial Blood Vessels, by Country USD Million (2022-2027)
  • Table 140. Asia Pacific Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 141. Asia Pacific Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 142. Asia Pacific Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 143. China Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 144. China Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 145. China Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 146. Japan Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 147. Japan Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 148. Japan Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 149. India Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 150. India Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 151. India Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 152. South Korea Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 153. South Korea Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 154. South Korea Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 155. Taiwan Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 156. Taiwan Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 157. Taiwan Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 158. Australia Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 159. Australia Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 160. Australia Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 161. Rest of Asia-Pacific Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 162. Rest of Asia-Pacific Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 163. Rest of Asia-Pacific Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 164. Europe Artificial Blood Vessels, by Country USD Million (2022-2027)
  • Table 165. Europe Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 166. Europe Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 167. Europe Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 168. Germany Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 169. Germany Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 170. Germany Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 171. France Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 172. France Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 173. France Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 174. Italy Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 175. Italy Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 176. Italy Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 177. United Kingdom Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 178. United Kingdom Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 179. United Kingdom Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 180. Netherlands Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 181. Netherlands Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 182. Netherlands Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 183. Rest of Europe Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 184. Rest of Europe Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 185. Rest of Europe Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 186. MEA Artificial Blood Vessels, by Country USD Million (2022-2027)
  • Table 187. MEA Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 188. MEA Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 189. MEA Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 190. Middle East Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 191. Middle East Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 192. Middle East Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 193. Africa Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 194. Africa Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 195. Africa Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 196. North America Artificial Blood Vessels, by Country USD Million (2022-2027)
  • Table 197. North America Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 198. North America Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 199. North America Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 200. United States Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 201. United States Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 202. United States Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 203. Canada Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 204. Canada Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 205. Canada Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 206. Mexico Artificial Blood Vessels, by Type USD Million (2022-2027)
  • Table 207. Mexico Artificial Blood Vessels, by Application USD Million (2022-2027)
  • Table 208. Mexico Artificial Blood Vessels, by End-User USD Million (2022-2027)
  • Table 209. Artificial Blood Vessels: by Type(USD/Units)
  • Table 210. Research Programs/Design for This Report
  • Table 211. Key Data Information from Secondary Sources
  • Table 212. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Blood Vessels: by Type USD Million (2016-2021)
  • Figure 5. Global Artificial Blood Vessels: by Application USD Million (2016-2021)
  • Figure 6. Global Artificial Blood Vessels: by End-User USD Million (2016-2021)
  • Figure 7. South America Artificial Blood Vessels Share (%), by Country
  • Figure 8. Asia Pacific Artificial Blood Vessels Share (%), by Country
  • Figure 9. Europe Artificial Blood Vessels Share (%), by Country
  • Figure 10. MEA Artificial Blood Vessels Share (%), by Country
  • Figure 11. North America Artificial Blood Vessels Share (%), by Country
  • Figure 12. Global Artificial Blood Vessels: by Type USD/Units (2016-2021)
  • Figure 13. Global Artificial Blood Vessels share by Players 2021 (%)
  • Figure 14. Global Artificial Blood Vessels share by Players (Top 3) 2021(%)
  • Figure 15. Global Artificial Blood Vessels share by Players (Top 5) 2021(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Maquet Cardiovascular (United States) Revenue, Net Income and Gross profit
  • Figure 18. Maquet Cardiovascular (United States) Revenue: by Geography 2021
  • Figure 19. Terumo Group (Japan) Revenue, Net Income and Gross profit
  • Figure 20. Terumo Group (Japan) Revenue: by Geography 2021
  • Figure 21. Gore (United States) Revenue, Net Income and Gross profit
  • Figure 22. Gore (United States) Revenue: by Geography 2021
  • Figure 23. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 24. B. Braun (Germany) Revenue: by Geography 2021
  • Figure 25. Bard (United States) Revenue, Net Income and Gross profit
  • Figure 26. Bard (United States) Revenue: by Geography 2021
  • Figure 27. Jotec GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Jotec GmbH (Germany) Revenue: by Geography 2021
  • Figure 29. LeMaitre Vascular (United States) Revenue, Net Income and Gross profit
  • Figure 30. LeMaitre Vascular (United States) Revenue: by Geography 2021
  • Figure 31. Perouse Medical (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Perouse Medical (United Kingdom) Revenue: by Geography 2021
  • Figure 33. Nicast (Israel) Revenue, Net Income and Gross profit
  • Figure 34. Nicast (Israel) Revenue: by Geography 2021
  • Figure 35. ShangHai (China) Revenue, Net Income and Gross profit
  • Figure 36. ShangHai (China) Revenue: by Geography 2021
  • Figure 37. Aortica Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 38. Aortica Corporation (United States) Revenue: by Geography 2021
  • Figure 39. Global Artificial Blood Vessels: by Type USD Million (2022-2027)
  • Figure 40. Global Artificial Blood Vessels: by Application USD Million (2022-2027)
  • Figure 41. Global Artificial Blood Vessels: by End-User USD Million (2022-2027)
  • Figure 42. South America Artificial Blood Vessels Share (%), by Country
  • Figure 43. Asia Pacific Artificial Blood Vessels Share (%), by Country
  • Figure 44. Europe Artificial Blood Vessels Share (%), by Country
  • Figure 45. MEA Artificial Blood Vessels Share (%), by Country
  • Figure 46. North America Artificial Blood Vessels Share (%), by Country
  • Figure 47. Global Artificial Blood Vessels: by Type USD/Units (2022-2027)
List of companies from research coverage that are profiled in the study
  • Maquet Cardiovascular (United States)
  • Terumo Group (Japan)
  • Gore (United States)
  • B. Braun (Germany)
  • Bard (United States)
  • Jotec GmbH (Germany)
  • LeMaitre Vascular (United States)
  • Perouse Medical (United Kingdom)
  • Nicast (Israel)
  • ShangHai (China)
  • Aortica Corporation (United States)
Select User Access Type

Key Highlights of Report


Aug 2022 208 Pages 75 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artificial Blood Vessels Market Quantitative research analysis
Global Artificial Blood Vessels Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Artificial Blood Vessels market are Maquet Cardiovascular (United States), Terumo Group (Japan), Gore (United States), B. Braun (Germany), Bard (United States), Jotec GmbH (Germany), LeMaitre Vascular (United States), Perouse Medical (United Kingdom), Nicast (Israel), ShangHai (China) and Aortica Corporation (United States).
In this highly competitive & fast evolving Artificial Blood Vessels industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Aortic Disease, Peripheral artery disease and Haemodialysis are the potential customers of Artificial Blood Vessels industry.

Know More About Global Artificial Blood Vessels Market Report?

Have a Query? Click Here

Other Related Reports

Non Coding Rna Assays Comprehensive Study by Application (Oncological Applications, Biomarker Development, Infectious Medicine, Other Applications), End User (Research Laboratories, Biotechnology Aca...
$ 3350
Rodent Surgery Services Comprehensive Study by Type (Aseptic Technique, Survival Surgery, Major Survival Surgery, Multiple Survival Surgeries), Application (Hamsters, Gerbils, Guinea Pig, Mice, Rats)...
$ 3750
Video Microscope Comprehensive Study by Type (3D, 2D), Application (Academic Research Institute, Forensic and Pathology Laboratory, Other), Industry Verticals (Biopharmaceutical, Food and Beverage, M...
$ 3450
Glass Bioreactors Comprehensive Study by Application (Pharmaceutical, Biotechnology, Vaccine Development, Biological Research, Others), Components (Microbial Cultures, Cell Cultures, Batch, Others), ...
$ 3450
Flexible Biomanufacturing Platform Comprehensive Study by Type (Single-use Technology, Modular Environment, Advanced Process Automation, Standardization), Modality (Machine Flexibility, Material Hand...
$ 3350
Cell Ion Indicators Comprehensive Study by Type (Calcium Indicators, Sodium Indicators, Magnesium Indicators, Zinc Indicators, PH Indicators), Application (Drug Discovery, Cell Signaling Studies, Fun...
$ 3650